Not Yet Recruiting PHASE2 INTERVENTIONAL 4-arm
NCT07373301
Phase IIa/b Trial of PvCS/Montanide ISA-51 Malaria Vaccine in Adults in Chocó, Colombia (PvCS/M51)
Determination of the Protective Efficacy of the PvCS/Montanide ISA-51 Vaccine Formulation Against Controlled Infection With Plasmodium Vivax Sporozoites
Sponsor: Johns Hopkins University
Updated 1 time since 2026 Last updated: Jan 20, 2026 Started: Jan 19, 2026 Primary completion: Jul 12, 2027 Completion: Jun 12, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE2 trial investigates Malaria Prevention and Plasmodium Vivax Infection and is currently actively recruiting participants. Johns Hopkins University leads this study, which shows 1 recorded version since 2026 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE2
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Johns Hopkins University
- Malaria Vaccine and Drug Development Center
Data source: Malaria Vaccine and Drug Development Center
For direct contact, visit the study record on ClinicalTrials.gov .